Opposite nociceptive effects of the arginine/NO/cGMP pathway stimulation in dermal and subcutaneous tissues

British Journal of Pharmacology

Volumn 138, Issue 7, 2003, Pages 1351-1357

  Vivancos, Gustavo G ^a   Parada, Carlos A ^a   Ferreira, Sérgio H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arginine NO cGMP; cAMP; cGMP; Intradermal PGE 2; Nitric oxide; PGE 2 hyperalgesia; PGE 2 hypernociception; Subcutaneous PGE 2

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ARGININE; CYCLIC GMP; DIBUTYRYL CYCLIC GMP; LINSIDOMINE; N(G) METHYLARGININE; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; HYPERALGESIA; INHIBITION KINETICS; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ARGININE; BUCLADESINE; CYCLIC GMP; DERMIS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; INJECTIONS, SUBCUTANEOUS; MALE; MOLSIDOMINE; NITRIC OXIDE; NOCICEPTORS; OMEGA-N-METHYLARGININE; OXADIAZOLES; PAIN MEASUREMENT; QUINOXALINES; RATS; RATS, WISTAR; SUBCUTANEOUS TISSUE; TIME FACTORS;

EID: 0038753921     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705181     Document Type: Article

References (42)

1. ALEY, K.O., MCCARTER, G. & LEVINE, J.D. (1998). Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci., 18, 7008-7014.
2. CICALA, C., JANARO, A., FIORUCCI, S., CALIGNANO, A., BUCCI, M., GERLI, R., SANTUCCI, L., WALLACE, J.L. & CIRINO, G. (2000). NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br. J. Pharmacol., 130, 1399-1405.
3. CUNHA, F.Q., TEIXEIRA, M.M. & FERREIRA, S.H. (1999). Pharmacological modulation of secondary mediator systems-cyclic AMP and cyclic GMP-on inflammatory hyperalgesia. Brit. J. Pharmacol., 127, 671-678.
4. DUARTE, I.D., DOS S., I, LORENZETTI, B.B. & FERREIRA, S.H. (1992). Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol., 217, 225-227.
5. DUARTE, I.D., LORENZETTI, B.B. & FERREIRA, S.H. (1990). Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol., 186, 289-293.
6. EVANS, A.R., VASKO, M.R. & NICOL, G.D. (1999). The cAMP transduction cascade mediates the PGE2-induced inhibition of potassium currents in rat sensory neurones. J. Physiol., 516, 163-178.
7. FERREIRA, S.H. (1972). Prostaglandins, aspirin-like drugs and analgesia. Nat. New Biol., 240, 200-203.
8. FERREIRA, S.H., DUARTE, I.D. & LORENZETTI, B.B. (1991). Molecular base of acetylcholine and morphine analgesia. Agents Actions Suppl., 32, 101-106.
9. FERREIRA, S.H., LORENZETTI, B.B. & CORREA, F.M. (1978b). Central and peripheral antialgesic action of aspirin-like drugs. Eur. J. Pharmacol., 53, 39-48.
10. FERREIRA, S.H., MONCADA, S. & VANE, J.R. (1971). Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat. New Biol., 231, 237-239.
11. FERREIRA, S.H. & NAKAMURA, M. (1979). I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins, 18, 179-190.
12. FERREIRA, S.H., NAKAMURA, M. & ABREU CASTRO, M.S. (1978a). The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins, 16, 31-37.
13. HABLER, H.J., JANIG, W. & KOLTZENBURG, M. (1988). A novel type of unmyelinated chemosensitive nociceptor in the acutely inflamed urinary bladder. Agents Actions, 25, 219-221.
14. HINGTGEN, C.M., WAITE, K.J. & VASKO, M.R. (1995). Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade. J. Neurosci., 15, 5411-5419.
15. HOLTHUSEN, H. & ARNDT, J. (1994). Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci. Lett., 165, 71-74.
16. KAWABATA, A., MANABE, S., MANABE, Y. & TAKAGI, H. (1994). Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol., 112, 547-550.
17. KERINS, D.M., ROBERTSON, R.M. & ROBERTSON, D. (2001). Drugs used for the treatment of myocardial ischemia. In The Pharmacological Basis of Therapeutics. 2001 ed. Hardman, J.G. & Limbird, L.E. pp. 843 870. New York: McGraw-Hill.
18. KHASAR, S., GREEN, PL.J. & LEVINE, J.D. (1993). Comparion of intradermal and subcutaneous hyperalgesic effects of inflammatory mediators in the rat. Neurosci. Lett., 153, 215-218.
19. KIM, S. & CHUNG, J. (1992). An experimental model for peripheral neurophathy produced by segmental spinal nerve ligation in the rat. Pain, 50, 355-363.
20. KRESS, M., KOLTZENBURG, M., REEH P.W. & HANDWERKER, H.O. (1992). Responsiveness and functional attributes of electrically localized terminals of cutaneous C-fibers in vivo and in vitro. J. Neurophysiol., 68, 581-595.
21. LORENZETTI, B. & FERREIRA, S. (1985). Mode of analgesic action of dipyrone: direct antagonism of inflammatory hyperalgesia. Eur. J. Pharmacol., 114, 375-381.
22. MCMAHON, S. & KOLTZENBURG, M. (1990a). The changing role of primary afferent neurones in pain. Pain, 43, 269-272.
23. MCMAHON, S.B. & KOLTZENBURG, M. (1990b). Novel classes of nociceptors: beyond Sherrington. Trends Neurosci., 13, 199-201.
24. MELLER, S.T., DYKSTRA, C. & GEBHART, G.F. (1992a). Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate- produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol., 214, 93-96.
25. MELLER, S.T., PECHMAN, P.S., GEBHART, G.F. & MAVES, T.J. (1992b). Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience, 50, 7-10.
26. MOLLER, K.A., JOHANSSON, B. & BERGE, O.G. (1998). Assessing mechanical allodynia in the rat paw with a new electronic algometer. J. Neurosci. Methods, 84, 41-47.
27. NAKAMURA, A., FUJITA, M. & SHIOMI, H. (1996). Involvement of endogenous nitric oxide in the mechanism of bradykinin-induced peripheral hyperalgesia. Br. J. Pharmacol., 117, 407-412.
28. OMOTE, K., KAWAMATA, T., NAKAYYAMA, Y., KAWAMATA, M., HAZAMA, K. & NAMIK, I.A. (2001). The effects of peripheral administration of a novel selective antagonist for prostaglandin E receptor subtype EP(1), ONO-8711, in a rat model of postoperative pain. Anesth. Analg., 92, 233-238.
29. PEHL, U. & SCHMID, H.A. (1997). Electrophysiological responses of neurons in the rat spinal cord to nitric oxide. Neuroscience, 77, 563-573.
30. PICOLO, G., GIORGI, R. & CURY, Y. (2000). Delta-opioid receptors and nitric oxide mediate the analgesic effect of Crotalus durissus terrificus snake venom. Eur. J. Pharmacol., 391, 55-62.
31. RODRIGUES, A.R. & DUARTE, I.D. (2000). The peripheral antinociceptive effect induced by morphine is associated with ATP-sensitive K(+) channels. Br. J. Pharmacol., 129, 110-114.
32. SAFIEH-GARABEDIAN, B., DARDENNE, M., KANAAN, S.A., ATWEH, S.F., JABBUR, S.J. & SAADE, N.E. (2000). The role of cytokines and prostaglandin-E(2) in thymulin induced hyperalgesia. Neuropharmacology, 39, 1653-1661.
33. SCHMIDT, R., SCHMELZ, M., FORSTER, C., RINGKAMP, M., TOREBJORK, E. & HANDWERKER, H. (1995). Novel classes of responsive and unresponsive C nociceptors in human skin. J. Neurosci., 15, 333-341.
34. SCHAIBLE, H.G. & SCHMIDT, R.F. (1985). Effects of an experimental arthritis on the sensory properties of fine articular afferent units. J. Neurophysiol., 54, 1109-1122.
35. SCHAIBLE, H.G. & SCHMIDT, R.F. (1988). Time course of mechanosensitivity changes in articular afferents during a developing experimental arthritis. J. Neurophysiol., 60, 2180-2195.
36. SMITH, J.B. & WILLIS, A.L. (1971). Aspirin selectively inhibits prostaglandin production in human platelets. Nat. New Biol., 231, 235-237.
37. SOARES, A.C. & DUARTE, I.D. (2001). Dibutyryl-cyclic GMP induces peripheral antinociception via activation of ATP-sensitive K(+) channels in the rat PGE2-induced hyperalgesic paw. Br. J. Pharmacol., 134, 127-131.
38. SOARES, A.C., LEITE, R., TATSUO, M.A. & DUARTE, I.D. (2000). Activation of ATP-sensitive K(+) channels mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur. J. Pharmacol., 400, 67-71.
39. SOUSA, A.M. & PRADO, W.A. (2001). The dual effect of a nitric oxide donor in nociception. Brain Res., 897, 9-19.
40. TAIWO, Y.O., BJERKNES, L.K., GOETZL, E.J. & LEVINE, J.D. (1989). Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience, 32, 577-580.
41. TONUSSI, C.R. & FERREIRA, F.H. (1994). Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur. J. Pharmacol., 45, 308-311.
42. VANE, J.R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol., 231, 232-235.